Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission
J Pidala, B Djulbegovic, C Anasetti… - Cochrane Database …, 2011 - cochranelibrary.com
Cochrane Database of Systematic Reviews, 2011•cochranelibrary.com
Background Consolidation chemotherapy, autologous hematopoietic cell transplantation
(HCT) and allogeneic HCT represent potential treatment alternatives for post‐remission
therapy in adult acute lymphoblastic leukemia (ALL), but there is genuine uncertainty
regarding the optimal approach. Objectives To assess the effect of matched sibling donor vs.
no donor status for adults with ALL in first complete remission (CR1).
(HCT) and allogeneic HCT represent potential treatment alternatives for post‐remission
therapy in adult acute lymphoblastic leukemia (ALL), but there is genuine uncertainty
regarding the optimal approach. Objectives To assess the effect of matched sibling donor vs.
no donor status for adults with ALL in first complete remission (CR1).
Background
Consolidation chemotherapy, autologous hematopoietic cell transplantation (HCT) and allogeneic HCT represent potential treatment alternatives for post‐remission therapy in adult acute lymphoblastic leukemia (ALL), but there is genuine uncertainty regarding the optimal approach.
Objectives
To assess the effect of matched sibling donor vs. no donor status for adults with ALL in first complete remission (CR1).
cochranelibrary.com